GCTLIMBS: Giant Cell Tumor of the Extremities Treated With Surgery and/or Medical Treatment

Sponsor
Istituto Ortopedico Rizzoli (Other)
Overall Status
Completed
CT.gov ID
NCT02996734
Collaborator
(none)
412
8

Study Details

Study Description

Brief Summary

The purpose of this project is to present the outcomes of patients with giant cell tumor of bone (GCTB) who were treated with surgery and/or medical treatment in a single institution.

Condition or Disease Intervention/Treatment Phase
  • Procedure: curettage and resection

Detailed Description

The investigators retrospectively review patients treated for GCTB of the extremities between 1990 and 2013 in a single institution. We evaluate the recurrence free survival rate after surgical and medical treatment of patients with GCTB of the extremities to determine the influence of the surgical approach, denosumab therapy, local tumor presentation, and demographic factors on the risk of recurrence.

Study Design

Study Type:
Observational
Actual Enrollment :
412 participants
Observational Model:
Case-Only
Time Perspective:
Retrospective
Official Title:
Il Tumore a Cellule Giganti Delle estermità
Study Start Date :
Apr 1, 2016
Actual Primary Completion Date :
Dec 1, 2016
Actual Study Completion Date :
Dec 1, 2016

Outcome Measures

Primary Outcome Measures

  1. local recurrence rate after surgical and medical treatment [within the first 36 months after surgery]

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • giant cell tumors of the extremities
Exclusion Criteria:
  • giant cell tumors of the spine and pelvis

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Istituto Ortopedico Rizzoli

Investigators

  • Study Director: Davide Donati, MD, Istituto Ortopedico Rizzoli

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Costantino Errani, MD; PhD., Istituto Ortopedico Rizzoli
ClinicalTrials.gov Identifier:
NCT02996734
Other Study ID Numbers:
  • 0008286
First Posted:
Dec 19, 2016
Last Update Posted:
Dec 22, 2016
Last Verified:
Dec 1, 2016
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Keywords provided by Costantino Errani, MD; PhD., Istituto Ortopedico Rizzoli
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 22, 2016